DOUBLE BLIND: Secondary use of health data and AI in clinical trials
27
2:00 PM - 2:45 PM
The secondary use of health data is becoming one of the biggest drivers of innovation across clinical research. But as AI technology advances and EU and UK regulations evolve, CROs and sponsors need to think ahead about how trial data might be used, or reused, in the future.
Join session moderator Ben Seretny, COO at The DPO Centre, alongside Lawrence Carter, DPO and Life Sciences Sector Lead, and Pippa Scotcher, DPO, for a forward-looking discussion on how AI and diverging governance frameworks are likely to impact the future of secondary data use and informed consent in clinical trials.
You’ll learn:
- How EU and UK regulatory reforms are reshaping secondary use of data
- The growing role of AI in expanding the value and risk of health data reuse
- What this means for informed consent and site-level secondary data use
- Practical steps CROs and sponsors can take to prepare for evolving governance and ethical requirements
This session will close with an open Q&A discussion, with practical insights on how to stay compliant, future-ready and confident as AI redefines the boundaries of research data.
Speakers
Lawrence Carter
Life Sciences Sector Lead & Data Protection Officer
Lawrence Carter is a highly accomplished Data Protection Officer (DPO) and the Life Sciences Sector Lead at The DPO Centre. As a Subject Matter Expert in clinical trials, healthcare, and information governance, he helps organisations meet the highest standards of EU and UK data protection law. Lawrence supports global sponsors in multi-jurisdictional studies, advising on secondary data use and the impact of AI in research, and helping ensure compliance supports both regulation and innovation.
Pippa Scotcher
Data Protection Officer
Pippa is a highly qualified Data Protection Officer with a background in law and specialist expertise in Life Sciences. She combines analytical precision with a pragmatic approach, helping global sponsors navigate the complex intersection of data protection law and clinical trial regulations. Pippa stays at the forefront of international privacy developments, offering valuable insights and guidance that help organisations strengthen accountability and achieve compliance excellence.
Replays
See all
27
2:00 PM - 2:45 PM